Pages that link to "Q54776759"
Jump to navigation
Jump to search
The following pages link to Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types. (Q54776759):
Displaying 21 items.
- The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival (Q24793695) (← links)
- p53-dependent anticancer effects of leptomycin B on lung adenocarcinoma (Q28292014) (← links)
- Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers (Q33283634) (← links)
- Selective intra-arterial infusion of rAd-p53 with chemotherapy for advanced oral cancer: a randomized clinical trial (Q34659341) (← links)
- Racial diversity of actionable mutations in non-small cell lung cancer (Q35007995) (← links)
- A novel radiation-induced p53 mutation is not implicated in radiation resistance via a dominant-negative effect (Q35099489) (← links)
- Molecular Markers with Predictive and Prognostic Relevance in Lung Cancer (Q35763239) (← links)
- Whole Exome Sequencing Identifies Frequent Somatic Mutations in Cell-Cell Adhesion Genes in Chinese Patients with Lung Squamous Cell Carcinoma (Q36209486) (← links)
- Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers (Q36728827) (← links)
- Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk. (Q36802615) (← links)
- Anti-tumor effects of atractylenolide I isolated from Atractylodes macrocephala in human lung carcinoma cell lines. (Q39068809) (← links)
- Potential importance of Maackia amurensis agglutinin in non-small cell lung cancer (Q39161714) (← links)
- Mutation and polymorphism in the EGFR-TK domain associated with lung cancer. (Q40149065) (← links)
- Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers (Q40165994) (← links)
- The Diagnostic Value of the Correlation between Serum Anti-p53 Antibody and Positron Emission Tomography Parameters in Lung Cancer (Q42372338) (← links)
- Etiologic value of p53 mutation spectra and differences with histology in lung cancers. (Q53034051) (← links)
- KRAS and TP53 mutations in bronchoscopy samples from former lung cancer patients. (Q53098874) (← links)
- TP53 genetic polymorphisms and environmental risk factors associated with cervical carcinogenesis in a cohort of Brazilian women with cervical lesions. (Q54423455) (← links)
- Large cell lung carcinoma with unusual imaging feature, immunophenotype and genetic finding. (Q54431715) (← links)
- Expression Levels of p53 Messenger RNA Detected by Real Time PCR in Tumor Tissue, Lymph Nodes and Peripheral Blood of Patients with Non-Small Cell Lung Cancer—New Perspectives for Clinicopathological Application (Q58050590) (← links)
- Effect of CYP1A1 MSPI Polymorphism on the Relationship Between TP53 Mutation and CDKN2A Hypermethylation in Non-small Cell Lung Cancer (Q82874963) (← links)